| Literature DB >> 31430258 |
Britta Höchsmann1,2, Yoshiko Murakami3,4, Makiko Osato3,5, Alexej Knaus6, Michi Kawamoto7, Norimitsu Inoue8, Tetsuya Hirata3, Shogo Murata3,9, Markus Anliker1, Thomas Eggermann10, Marten Jäger11, Ricarda Floettmann11, Alexander Höllein12, Sho Murase7, Yasutaka Ueda5, Jun-Ichi Nishimura5, Yuzuru Kanakura5, Nobuo Kohara7, Hubert Schrezenmeier1, Peter M Krawitz6, Taroh Kinoshita3,4.
Abstract
Patients with paroxysmal nocturnal hemoglobinuria (PNH) have a clonal population of blood cells deficient in glycosylphosphatidylinositol-anchored (GPI-anchored) proteins, resulting from a mutation in the X-linked gene PIGA. Here we report on a set of patients in whom PNH results instead from biallelic mutation of PIGT on chromosome 20. These PIGT-PNH patients have clinically typical PNH, but they have in addition prominent autoinflammatory features, including recurrent attacks of aseptic meningitis. In all these patients we find a germ-line point mutation in one PIGT allele, whereas the other PIGT allele is removed by somatic deletion of a 20q region comprising maternally imprinted genes implicated in myeloproliferative syndromes. Unlike in PIGA-PNH cells, GPI is synthesized in PIGT-PNH cells and, since its attachment to proteins is blocked, free GPI is expressed on the cell surface. From studies of patients' leukocytes and of PIGT-KO THP-1 cells we show that, through increased IL-1β secretion, activation of the lectin pathway of complement and generation of C5b-9 complexes, free GPI is the agent of autoinflammation. Eculizumab treatment abrogates not only intravascular hemolysis, but also autoinflammation. Thus, PIGT-PNH differs from PIGA-PNH both in the mechanism of clonal expansion and in clinical manifestations.Entities:
Keywords: Complement; Glycobiology; Hematology; Inflammation
Mesh:
Substances:
Year: 2019 PMID: 31430258 PMCID: PMC6877298 DOI: 10.1172/JCI123501
Source DB: PubMed Journal: J Clin Invest ISSN: 0021-9738 Impact factor: 14.808